Even with vaccines are available, people will need to take additional COVID-19 precautions including:
Show All Answers
Texas continues to receive doses of the Pfizer and Moderna COVID-19 vaccines, and is distributing statewide to hospitals, pharmacies, local health departments, freestanding ERs and other clinics. As vaccine availability increases in 2021, people will be able to get vaccinated at doctor’s offices, pharmacies, hospitals and other “usual” sites. You should contact your regular provider of vaccines to see whether they will be a provider of the COVID-19 vaccine.
If you are a front-line healthcare worker or resident of a long-term care facility, you are eligible now to receive the vaccine, since December 14. This group is considered Phase 1A.
If you are in Phase 1B, you are also eligible to get the COVID-19 vaccine, depending on availability and the vaccine provider. Vaccine supply remains limited, but more vaccine will be delivered to providers each week. Phase 1B recipients include:
Local jurisdiction coalitions have been identified at the federal level as a best practice and are key to successful rapid vaccine distribution planning. Boerne and Kendall County continue to work with state and local partners to distribute COVID-19 vaccines to critical populations, within the phases designated by the Texas Department of State Health Services. Each provider will likely have their own sign-up system, though they have all been trained on providing the vaccine and the allocation order by Texas DSHS. The city continues to reach out to potential providers and will update information as it is received.
The federal government, under the umbrella of Operation Warp Speed has been working since the start of the pandemic to make a safe and effective COVID-19 vaccine available. The U.S. Food and Drug Administration (FDA) carefully reviews all safety data from clinical trials and an authorizes emergency vaccine use only when the expected benefits outweigh potential risks. The Advisory Committee on Immunization Practices (ACIP) reviews all safety data before recommending any COVID-19 vaccine for use. Learn how ACIP makes vaccine recommendations. FDA and CDC will continue to monitor the safety of COVID-19 vaccines, to make sure even very rare side effects are identified.
With the approval of two vaccines, many vaccine safety monitoring systems watch for possible side effects. This continued monitoring can pick up on side effects that may not have been seen in clinical trials. V-SAFE is a new smartphone-based, after-vaccination health checker for people who receive COVID- 19 vaccines. V-SAFE will use text messaging and web surveys from CDC to check in with vaccine recipients for health problems following COVID-19 vaccination. The system also will provide telephone follow up to anyone who reports medically significant side effects. Learn more about V-SAFE here (PDF) and here (PDF).